Cann Group Ltd
ASX:CAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cann Group Ltd
ASX:CAN
|
AU |
|
P
|
Premium Leisure Corp
XPHS:PLC
|
PH |
|
B
|
Beauty Farm Medical & Health Industry Inc
HKEX:2373
|
CN |
|
MLP Saglik Hizmetleri AS
IST:MPARK.E
|
TR |
|
Hawaiian Holdings Inc
NASDAQ:HA
|
US |
|
G
|
Grammer AG
XETRA:GMM
|
DE |
|
Zanyu Technology Group Co Ltd
SZSE:002637
|
CN |
|
Huber+Suhner AG
LSE:0QNH
|
CH |
|
Figeac Aero SARL
PAR:FGA
|
FR |
|
China Railway Construction Corp Ltd
HKEX:1186
|
CN |
|
P
|
Parkwood Holdings Bhd
KLSE:PARKWD
|
MY |
|
D
|
DTC Industries PCL
SET:DTCI
|
TH |
|
Future World Holdings Ltd
HKEX:572
|
HK |
|
T
|
Tupperware Brands Corp
SWB:TUP
|
US |
Cann Group Ltd
Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The firm has established research and cultivation facilities in Melbourne and is developing a cultivation facility near Mildura, Victoria. The company focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. The firm has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. The company focuses on plant genetics, breeding, cultivation, extraction, analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The firm has established research and cultivation facilities in Melbourne and is developing a cultivation facility near Mildura, Victoria. The company focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. The firm has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. The company focuses on plant genetics, breeding, cultivation, extraction, analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
